The doctors and researchers at the Penn Pancreatic Cancer Research Center (Perelman School of Medicine at the University of Pennsylvania) examine different aspects of pancreatic cancer to find better treatments.
This research was presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of over 30,000 oncology professionals in Chicago.
“There's a lot of miscommunication and number one, I would tell them you don't need to face these decisions alone,” Dr. Pat Basu said in an interview addressing patient’s fear in the midst of the COVID-19 pandemic.
“‘Compassionate,’ “cheerleader,’ ‘friend’ ‘supporter’ and ‘angel’ are just a few words used by patients and staff to describe Harding Cranford, RN, OCN,” wrote Erin Auten, RN.
Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer following cystectomy and chemotherapy.
New drug treatments are helping patients with advanced prostate cancer to live longer.
Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.
Nita Karnik Lee, MD, MPH, of The University of Chicago Medicine, discusses what patients with ovarian cancer should know about when entering survivorship.
To ease ‘chemo brain,’ a nurse researcher combined mindfulness with physical exercise.
Apps and online resources can help the mind, body and soul.
How a cancer diagnosis leaves one woman feeling humbled.
After her daughter was diagnosed, Celia Miltz founded the Friends of ET Research.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, and Sara A. Hurvitz, M.D., discuss treatment approaches and modifications during the COVID-19 pandemic.
Maurie Markman urges patients with ovarian cancer who have undergone surgery to speak with their gynecologic oncologist and see if IP therapy is right for them.
The science behind immunotherapy and gastrointestinal cancers is not quite perfected yet, but one subset of patients is seeing remarkable results.
By gathering teams of cancer-fighting scientists, Stand Up To Cancer hopes to one day eradicate the disease.
Under Medicare’s new oncology care model, patient-centric treatment aims to save money while improving health outcomes.
The National Cancer Institute intensifies quality cancer research and discussion about complementary and alternative medicine.
Here, Lea White shares her Extraordinary Healer nomination essay of her oncology nurse, Cindy DeLeon Trevino, ANP-BC, AOCNP, BMTCN, of the University of Texas MD Anderson Cancer Center in Houston, Texas.
An early clinical trial participant likens his journey into the unknown to a space mission.
There are many exciting advances happening in the field of mantle cell lymphoma.
Traveling helped me remove myself from the storyline of cancer and reconnect with the world around me.
Since 2000, antibody-drug conjugates have been approved by the Food and Drug Administration for various cancer types, such as breast cancer.
A nonprofit is partnering with performance artists to stimulate end-of-life discussions.